These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 7188137)

  • 1. The effect of Cavinton on cerebrovascular resistance and its use in ophthalmological patients. A double-blind trial.
    Imre G; Németh B
    Ther Hung; 1981; 29(3):120-3. PubMed ID: 7188137
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of corglycon and cavinton on the hemodynamics of patients with initial manifestations of insufficiency of cerebral circulation].
    Ishchenko MM; Nechaĭ EE
    Vrach Delo; 1988 May; (5):53-5. PubMed ID: 3420871
    [No Abstract]   [Full Text] [Related]  

  • 3. [A differential approach to cavinton and finoptin treatment of patients with circulatory encephalopathies].
    Burtsev EM; Shprakh VV; Savkov VS
    Ross Med Zh; 1992; (2):41-3. PubMed ID: 1643337
    [No Abstract]   [Full Text] [Related]  

  • 4. Cerebral regulation-cerebral regulators.
    Braun P
    Ther Hung; 1980; 28(3):98-104. PubMed ID: 7221974
    [No Abstract]   [Full Text] [Related]  

  • 5. [Disturbances of brain metabolism in blood circulation disorders and their correction with cavinton].
    Zhloba AA; Nikitina VV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(4):67-9. PubMed ID: 16737165
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of cavinton drip infusion in ophthalmology. Effect of cavinton drip infusion on the peripheral resistance of internal carotid artery.
    Imre G
    Ther Hung; 1985; 33(4):186-8. PubMed ID: 3842015
    [No Abstract]   [Full Text] [Related]  

  • 7. [Agents to improve cerebrovascular circulation and cerebral metabolism--vinpocetine].
    Tamaki N; Matsumoto S
    Nihon Rinsho; 1985 Feb; 43(2):376-8. PubMed ID: 2987571
    [No Abstract]   [Full Text] [Related]  

  • 8. [On the role of vincamine in the therapy of cerebrovascular diseases and impairment of cerebral function (author's transl)].
    Witzmann HK; Blechacz W
    Arzneimittelforschung; 1977; 27(6a):1238-47. PubMed ID: 332190
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of cyclandelate on cerebral circulation. A double blind trial with clinical and radiocirculographic investigations.
    Eichhorn O
    Vasc Dis; 1965 Nov; 2(6):305-15. PubMed ID: 5323511
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of circulatory encephalopathy with Cavinton].
    Lebedeva NV; Chukhrova VA; Solov'ev OU; Nepesov RR
    Klin Med (Mosk); 1997; 75(11):51-3. PubMed ID: 9490359
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of ethyl apovincaminate on the cerebral circulation. Studies in patients with obliterative cerebral arterial disease.
    Solti F; Iskum M; Czakó E
    Arzneimittelforschung; 1976; 26(10a):1945-7. PubMed ID: 1037221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Vincamine in cerebral arteriosclerosis: therapeutic effects evaluated clinically and by retinal fluoro-angiography].
    Ardito R
    Clin Ter; 1979 Mar; 88(5):461-12. PubMed ID: 466968
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prospects of using cavinton for treating Ménière's disease].
    Nikolaev MP; Konstantinova ZD; Mertsalova ON; Sheremet AS
    Vestn Otorinolaringol; 1980; (3):18-22. PubMed ID: 7385520
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapeutic influence of vincamine on impairment of cerebral performance in elderly patients. Results of a double-blind study (author's transl)].
    Schenker H
    Schweiz Rundsch Med Prax; 1979 Jul; 68(31):1005-11. PubMed ID: 379854
    [No Abstract]   [Full Text] [Related]  

  • 15. [Double-blind controlled study of the effects of vincamine hydrochloride on some parameters of cardiovascular function in aged bronchopneumopathic patients].
    Mazzola C; Della Torre F; Izzo M; Colombo Pirola L
    Clin Ter; 1979 Dec; 91(5):485-503. PubMed ID: 397034
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of cavinton and sulfocamphocain on systemic and cerebral hemodynamics in patients with early forms of cerebrovascular diseases].
    Ishchenko MM; Shkrobot SI; Borak VT
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(8):1160-4. PubMed ID: 3673409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Agents to improve cerebrovascular circulation and cerebral metabolism--brovincamine].
    Maeda T
    Nihon Rinsho; 1985 Feb; 43(2):389-91. PubMed ID: 3889412
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of vinpocetine on cerebral blood flow in patients with cerebrovascular disorders.
    Tamaki N; Kusunoki T; Matsumoto S
    Ther Hung; 1985; 33(1):13-21. PubMed ID: 3841996
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical, psychological and neurophysiological results of double-blind study on vincamine-cromesilate in patients with cerebro-vascular insufficiency (author's transl)].
    Mikus P
    Arzneimittelforschung; 1978; 28(11):2165-8. PubMed ID: 582924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A cholinergic participation in the increase of cerebral cortical blood flow induced by vincamine (rat) (author's transl)].
    Rovere AA
    Acta Physiol Lat Am; 1976; 26(3):206-11. PubMed ID: 1036425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.